Profound Medical Corp. PROF
Set alert
6.57 USD +0.71 +12.12%
At close · Oct 30
6.34 -0.23 -3.50%
After hours · Oct 30, 4:33 PM ET
5.88 Day range 6.63
5.06 52-week range 8.65
- YTD
- -16.52%
- 1 year
- +7.35%
- Open
- 5.98
- Prev close
- 5.86
- Mkt cap
- 240.02M
- Vol
- 475.51K
- Avg vol
- 185.65K
- EPS
- -0.99
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 5.88
- High
- 6.63
- Forward P/E
- -7.95
- Beta
- 0.83
- Short ratio
- 7.87
- Inst. own
- 35.99%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 8, 2024
- 50-d avg
- 7.73
- 200-d avg
- 8.29
- 1y target
- 15.30
2Y chart
Events in this range
- Nov 7, 2024Earnings: -0.38; estimate -0.33; surprise -15.15%
Signals (108)
| Name | Date | Ago |
|---|---|---|
| MACD: Sell Signal | Oct 20, 2026 | 1 week ago |
| SMA: Bearish | Oct 15, 2026 | 2 weeks ago |
| SMA: Bearish | Oct 14, 2026 | 2 weeks ago |
| SMA: Bullish | Oct 8, 2026 | 3 weeks ago |
| SMA: Bullish | Oct 8, 2026 | 3 weeks ago |
| MACD: Buy Signal | Sep 30, 2026 | 1 month ago |
| RSI: Oversold | Sep 14, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 10, 2026 | 1 month ago |
| RSI: Oversold | Sep 10, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 9, 2026 | 1 month ago |
| SMA: Bearish | Aug 28, 2026 | 2 months ago |
| SMA: Bearish | Aug 27, 2026 | 2 months ago |
| SMA: Bullish | Aug 26, 2026 | 2 months ago |
| SMA: Bullish | Aug 26, 2026 | 2 months ago |
| SMA: Bearish | Aug 20, 2026 | 2 months ago |
| SMA: Bearish | Aug 20, 2026 | 2 months ago |
| SMA: Bullish | Aug 19, 2026 | 2 months ago |
| SMA: Bullish | Aug 18, 2026 | 2 months ago |
| SMA: Bearish | Aug 13, 2026 | 2 months ago |
| SMA: Bearish | Aug 11, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 11, 2026 | 2 months ago |
| RSI: Overbought | Aug 3, 2026 | 2 months ago |
| MACD: Buy Signal | Jul 27, 2026 | 3 months ago |
| SMA: Bullish | Jul 21, 2026 | 3 months ago |
| SMA: Bearish | Jul 16, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 16, 2026 | 3 months ago |
| SMA: Bullish | Jul 2, 2026 | 4 months ago |
| MACD: Buy Signal | Jul 1, 2026 | 4 months ago |
| SMA: Bullish | Jun 29, 2026 | 4 months ago |
| SMA: Bearish | Jun 25, 2026 | 4 months ago |
| SMA: Bearish | Jun 22, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 22, 2026 | 4 months ago |
| SMA: Bullish | Jun 18, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 18, 2026 | 4 months ago |
| SMA: Bearish | Jun 10, 2026 | 4 months ago |
| SMA: Bullish | Jun 9, 2026 | 4 months ago |
| SMA: Bearish | Jun 5, 2026 | 4 months ago |
| SMA: Bullish | Jun 4, 2026 | 4 months ago |
| SMA: Bearish | Jun 2, 2026 | 5 months ago |
| MACD: Sell Signal | May 15, 2026 | 5 months ago |
| MACD: Buy Signal | May 5, 2026 | 5 months ago |
| MACD: Sell Signal | May 4, 2026 | 6 months ago |
| MACD: Buy Signal | May 1, 2026 | 6 months ago |
| MACD: Sell Signal | Apr 30, 2026 | 6 months ago |
| SMA: Bullish | Apr 15, 2026 | 6 months ago |
| SMA: Bullish | Apr 13, 2026 | 6 months ago |
| SMA: Bearish | Apr 10, 2026 | 6 months ago |
| SMA: Bullish | Mar 31, 2026 | 7 months ago |
| SMA: Bearish | Mar 30, 2026 | 7 months ago |
| SMA: Bullish | Mar 26, 2026 | 7 months ago |
| MACD: Buy Signal | Mar 26, 2026 | 7 months ago |
| SMA: Bearish | Mar 6, 2026 | 7 months ago |
| SMA: Bearish | Mar 6, 2026 | 7 months ago |
| MACD: Sell Signal | Mar 6, 2026 | 7 months ago |
| RSI: Oversold | Mar 6, 2026 | 7 months ago |
| SMA: Bullish | Mar 4, 2026 | 8 months ago |
| SMA: Bullish | Feb 26, 2026 | 8 months ago |
| MACD: Buy Signal | Feb 19, 2026 | 8 months ago |
| SMA: Bearish | Feb 3, 2026 | 9 months ago |
| MACD: Sell Signal | Jan 14, 2026 | 9 months ago |
| RSI: Overbought | Jan 12, 2026 | 9 months ago |
| RSI: Overbought | Jan 8, 2026 | 9 months ago |
| MACD: Buy Signal | Jan 7, 2026 | 9 months ago |
| MACD: Sell Signal | Dec 24, 2025 | 10 months ago |
| MACD: Buy Signal | Dec 3, 2025 | 11 months ago |
| MACD: Sell Signal | Dec 2, 2025 | 11 months ago |
| MACD: Buy Signal | Nov 28, 2025 | 11 months ago |
| MACD: Sell Signal | Nov 19, 2025 | 11 months ago |
| MACD: Buy Signal | Nov 11, 2025 | 11 months ago |
| MACD: Sell Signal | Nov 3, 2025 | 12 months ago |
| MACD: Buy Signal | Oct 31, 2025 | 1 year ago |
| SMA: Bullish | Oct 28, 2025 | 1 year ago |
| SMA: Bearish | Oct 22, 2025 | 1 year ago |
| SMA: Bullish | Oct 20, 2025 | 1 year ago |
| MACD: Sell Signal | Oct 16, 2025 | 1 year ago |
| SMA: Bearish | Oct 15, 2025 | 1 year ago |
| SMA: Bullish | Oct 7, 2025 | 1 year ago |
| RSI: Overbought | Oct 7, 2025 | 1 year ago |
| SMA: Bullish | Sep 23, 2025 | 1 year ago |
| MACD: Buy Signal | Sep 16, 2025 | 1 year ago |
| RSI: Oversold | Sep 9, 2025 | 1 year ago |
| RSI: Oversold | Aug 15, 2025 | 1 year ago |
| MACD: Sell Signal | Aug 13, 2025 | 1 year ago |
| MACD: Buy Signal | Aug 11, 2025 | 1 year ago |
| SMA: Bearish | Jul 25, 2025 | 1 year ago |
| SMA: Bullish | Jul 22, 2025 | 1 year ago |
| MACD: Sell Signal | Jun 24, 2025 | 1 year ago |
| RSI: Overbought | Jun 16, 2025 | 1 year ago |
| RSI: Overbought | Jun 10, 2025 | 1 year ago |
| SMA: Bullish | May 27, 2025 | 1 year ago |
| MACD: Buy Signal | May 16, 2025 | 1 year ago |
| MACD: Sell Signal | May 13, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 22, 2025 | 1 year ago |
| RSI: Oversold | Mar 31, 2025 | 1 year ago |
| SMA: Bearish | Mar 21, 2025 | 1 year ago |
| SMA: Bullish | Mar 20, 2025 | 1 year ago |
| SMA: Bearish | Mar 14, 2025 | 1 year ago |
| SMA: Bullish | Mar 12, 2025 | 1 year ago |
| MACD: Sell Signal | Mar 10, 2025 | 1 year ago |
| SMA: Bearish | Mar 7, 2025 | 1 year ago |
| SMA: Bullish | Mar 4, 2025 | 1 year ago |
| SMA: Bearish | Feb 28, 2025 | 1 year ago |
| SMA: Bullish | Feb 19, 2025 | 1 year ago |
| MACD: Buy Signal | Feb 14, 2025 | 1 year ago |
| RSI: Oversold | Feb 4, 2025 | 1 year ago |
| RSI: Oversold | Jan 29, 2025 | 1 year ago |
| MACD: Sell Signal | Jan 21, 2025 | 1 year ago |
| MACD: Buy Signal | Dec 31, 2024 | 1 year ago |
Key statistics
- Market cap
- 210.20M
- Enterprise value
- 157.76M
- Trailing P/E
- 0.00
- Forward P/E
- -7.95
- PEG ratio
- 0.00
- Price / sales
- 23.40
- Price / book
- 5.55
- EPS (TTM)
- -1.34
- Beta
- 0.83
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 8.98M
- Revenue growth
- 63.90%
- Free cash flow
- -14.79M
- Total cash
- 27.12M
- Total debt
- 6.23M
- Return on equity
- -90.17%
- Shares outstanding
- 30.03M
- Short % of float
- 0.00%
- 50-day average
- 7.73
- 200-day average
- 8.29
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 15.30 +132.9% upside
Now 6.57
- Target (low)
- 12.00
- Target (mean)
- 15.30
- Target (high)
- 18.00
Ratings (0m) 5 5 buy · 0 hold · 0 sell
- Strong buy0
- Buy5
- Hold0
- Sell0
- Strong sell0
Next earnings
Aug 8, 2024
Expected Aug 8, 2024. Consensus EPS estimate -0.345.
Financials — quick view
PROF Revenue — quarterly 2.48M
PROF Net income — quarterly -9.54M
PROF EPS — quarterly -0.26
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 7, 2024 | Sep 1, 2024 | -0.33 | -0.38 | -0.05 | -15.15% |
| Aug 8, 2024 | Jun 1, 2024 | -0.28 | -0.28 | 0.00 | 0.00% |
| Aug 8, 2024 | Jun 1, 2024 | -0.28 | — | — | — |
| May 9, 2024 | Mar 1, 2024 | -0.31 | — | — | — |
| May 9, 2024 | Mar 1, 2024 | -0.31 | -0.26 | +0.05 | +16.13% |
| Mar 7, 2024 | Dec 1, 2023 | -0.28 | -0.42 | -0.14 | -50.00% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jul 16, 2024 | Stifel | up | Hold | Buy |
| Mar 11, 2024 | Alliance Global Partners | main | Buy | Buy |
| Mar 8, 2024 | Stifel | main | Hold | Hold |
| Jan 4, 2024 | Alliance Global Partners | main | Buy | Buy |
| Nov 28, 2023 | Stifel | init | — | Hold |
| Aug 4, 2023 | Raymond James | down | Strong Buy | Outperform |
About Profound Medical Corp.
Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system combines magnetic resonance imaging(MRI), robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to provide precise, flexible, and durable ablation of a surgeon defined region of prostate and protect the urethra and rectum. The company also offers Sonalleve, which combines real-time MRI and thermometry for the treatment of uterine fibroids, adenomyotic tissue, palliative pain treatment of bone metastases, osteoid osteoma, and management of benign tumors. Profound Medical Corp. is headquartered in Mississauga, Canada.
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- Canada
- Website
- profoundmedical.com
News
- 12 Health Care Stocks Moving In Friday's Intraday Session
- Wall Street Analysts Believe Profound Medical (PROF) Could Rally 89.93%: Here's is How to Trade
- Profound Medical Strikes Supply, Distribution Deal With iMRI Division Of Cook Medical To Expand Sales Of TULSA-PRO System In U.S.
- Profound Medical and Cook Medical's iMRI Division Partner to Expand U.S. TULSA-PRO® Sales Channels and Drive Recurring Revenue Growth
- Emmy-Award Winning Television Host Montel Williams to Join Next ‘Let's Huddle' Webinar
- Does Profound Medical (PROF) Have the Potential to Rally 58.77% as Wall Street Analysts Expect?
- TULSA Abstracts at the 15th Interventional MRI Symposium Strengthen Real-World Evidence, Clinical Differentiation, and Platform Expansion Opportunity
- Strength Seen in Profound Medical (PROF): Can Its 21.7% Jump Turn into More Strength?
- Profound Medical Signs Agreement With Telix Pharmaceuticals To Educate Urologists, Radiologists, Nuclear Medicine Physicians, Prostate Cancer Centers Over Roles Of Telix’s Advanced Prostate-Specific Membrane Antigen
- Profound Medical and Telix Pharmaceuticals Enter Co-Education Agreement to Advance PSMA-Informed Prostate Care
Your note
Sign in to keep a note on PROF — it syncs with the Stock Master app.
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| FIL LTD | 5.11% | 1,535,000 | 10.74M | Sep 29, 2024 |
| Gagnon Securities, LLC | 4.89% | 1,467,247 | 10.27M | Sep 29, 2024 |
| Letko, Brosseau & Associates Inc. | 3.99% | 1,198,775 | 8.39M | Sep 29, 2024 |
| Raymond James Financial Services Advisors, Inc. | 2.53% | 760,457 | 5.32M | Sep 29, 2024 |
| Timelo Investment Management Inc. | 2.50% | 751,807 | 5.26M | Sep 29, 2024 |
| Gagnon Advisors, LLC | 2.49% | 747,226 | 5.23M | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Royce Micro-Cap Fund | 0.76% | 227,937 | 1.60M | Sep 29, 2024 |
| Royce Micro Cap Trust | 0.63% | 189,100 | 1.32M | Sep 29, 2024 |
| Royce Capital Fund-Micro-Cap Portfolio | 0.33% | 100,163 | 701.14K | Sep 29, 2024 |
| Royce Small-Cap Fund | 0.17% | 52,098 | 364.69K | Sep 29, 2024 |
| Fidelity NASDAQ Composite Index Fund | 0.05% | 14,049 | 98.34K | Oct 30, 2024 |
| Dimensional ETF Tr-Dimensional International Small Cap ETF | 0.00% | 1,188 | 8.32K | Jul 30, 2024 |